Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Alopecia Drugs Market - Analysis, Technolgies & Forecasts to 2020 - Key Vendors are GlaxoSmithKline, Johnson & Johnson & Merck - Research and Markets

Research and Markets
Posted on: 25 Nov 16

Research and Markets has announced the addition of the "Global Alopecia Drugs Market 2016-2020" report to their offering.

The report forecasts the global alopecia drugs market to grow at a CAGR of 5.02% during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, the alopecia market has a huge unmet need in terms of approved therapies. Globally, the market has only two approved drugs, one (minoxidil) being topical in nature whereas, other (finasteride) being oral. However, these two drugs have a huge success story with the individuals affected with alopecia and command nearly 80% of the market share. Lately, the Japanese, South Korean, and Australian market have seen the entry of AVODART, impact of which is yet to be quantified by the market. However, considering the efficacy and safety of this drug, once approved for the US and the EU market, the alopecia drug market should witness stronger growth on a global scale.

Key vendors:

  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Overview: Alopecia

Part 06: Pipeline portfolio

Part 07: Market landscape

Part 08: Key buying criteria

Part 09: Market segmentation by ROA

Part 10: Market segmentation by gender

Part 11: Geographical segmentation

Part 12: Market drivers

Part 13: Impact of drivers

Part 14: Market challenges

Part 15: Impact of drivers and challenges

Part 16: Market trends

Part 17: Vendor landscape

Part 18: Key vendor analysis

Part 19: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/5lxwf2/global_alopecia

View source version on businesswire.com: http://www.businesswire.com/news/home/20161125005155/en/

Business Wire
www.businesswire.com

Last updated on: 25/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.